Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2
Introduction 11
2.1 What Is This Report About? 11
2.2 Definitions
11
3 Healthcare Sector Review 13
3.1 Healthcare Sector Review 13
3.2 Healthcare Expenditure 13
3.3 Healthcare Infrastructure 14
3.4
Healthcare Policy 17
4 Diabetes Care Devices in France 18
4.1 Diabetes
Care Devices Overall Revenues (2000-2012) 18
4.2 Diabetes Care Devices
Overall Volume (2000-2012) 24
4.3 Diabetes Care Devices Overall Company
Share (2006-2007) 27
5 Glucose Monitoring in France 28
5.1 Glucose
Monitoring Overall Revenues (2000-2012) 28
5.2 Glucose Monitoring Overall
Volume (2000-2012) 36
5.3 Glucose Monitoring Average Price (2000-2012)
42
5.4 Glucose Monitoring Distribution Share (2006-2007) 46
5.5
Glucose Monitoring Company Share (2006-2007) 47
6 Insulin Delivery in
France 48
6.1 Insulin Delivery Overall Revenues (2000-2012) 48
6.2
Insulin Delivery Overall Volume (2000-2012) 60
6.3 Insulin Delivery
Average Price (2000-2012) 69
6.4 Insulin Delivery Distribution Share
(2006-2007) 77
6.5 Insulin Delivery Company Share (2006-2007) 78
7 F.
Hoffmann-La Roche Ltd. Company Profile 79
7.1 Company Overview 79
7.2
Business Overview 79
7.3 Value Chain Analysis 83
7.4 SWOT Analysis
86
7.5 Financial and Operational Review 90
7.6 Locations And
Subsidiaries 92
8 LifeScan, Inc. Company Profile 94
8.1 Company
Overview 94
8.2 Business Overview 94
8.3 Locations And Subsidiaries
96
8.4 LifeScan, Inc. Pipeline Products 97
9 Abbott Laboratories
Company Profile 99
9.1 Company Overview 99
9.2 Business Overview
99
9.3 Value Chain Analysis 104
9.4 SWOT Analysis 106
9.5
Financial and Operational Review 110
9.6 Locations and Subsidiaries
112
9.7 Abbott Laboratories Pipeline Products 113
10 Novo Nordisk A/S
Company Profile 121
10.1 Company Overview 121
10.2 Business Overview
121
10.3 Locations and Subsidiaries 123
10.4 Novo Nordisk A/S Pipeline
Products 125
11 Bayer HealthCare AG Company Profile 127
11.1 Company
Overview 127
11.2 Business Overview 127
11.3 Value Chain Analysis
133
11.4 SWOT Analysis 135
11.5 Locations and Subsidiaries 139
11.6 Bayer HealthCare AG Pipeline Products 140
12 Regulation System
145
12.1 Medical Equipment Approval Process 145
12.2 Post Market
Surveillance (PMS) 158
13 Pricing and Reimbursement 159
13.1 Pricing
and Reimbursement Policies 159
14 Distribution Structure 160
15
Appendix 161
15.1 Global Markets Direct Research Methodology 161
15.2
Coverage 162
15.3 Secondary Research 162
15.4 Primary Research 163
15.5 Models 163
15.6 Forecasts 164
15.7 Expert Panels 164
15.8
Currency Conversion 165
15.9 Contact Us 166
15.10 Disclaimer 166
1.1 List of Tables
Table 1: Number of Doctors by Specialty in France,
2003-2007 21
Table 2: Number of Hospital Wards by Specialty in France,
2003-2007 22
Table 3: Diabetes Care Devices, France, Overall Revenues ($
mn), 2000-2012 24
Table 4: Diabetes Care Devices, France, Overall Revenues
($ mn), Historic, 2000-2007 25
Table 5: Diabetes Care Devices, France,
Overall Revenues ($ mn), Forecast, 2007-2012 26
Table 6: Diabetes Care
Devices, France, Overall Revenues ($ mn), 2000-2012 27
Table 7: Diabetes
Care Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 28
Table 8: Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast,
2007-2012 29
Table 9: Diabetes Care Devices, France, Overall Volume
(Units), 2000-2012 30
Table 10: Diabetes Care Devices, France, Overall
Volume (Units), Historic, 2000-2007 31
Table 11: Diabetes Care Devices,
France, Overall Volume (Units), Forecast, 2007-2012 32
Table 12: Diabetes
Care Devices, France, Overall Company Share by Revenue ($ mn), 2006-2007
33
Table 13: Glucose Monitoring, France, Overall Revenues ($ mn),
Historic, 2000-2007 34
Table 14: Glucose Monitoring, France, Overall
Revenues ($ mn), Forecast, 2007-2012 35
Table 15: Glucose Monitoring,
France, Revenue by Segment ($ mn), Historic, 2000-2007 36
Table 16:
Glucose Monitoring, France, Revenue by Segment ($ mn), Forecast, 2007-2012
37
Table 17: Blood Glucose Test Strips, France, Overall Revenues ($ mn),
Historic, 2000-2007 38
Table 18: Blood Glucose Test Strips, France,
Overall Revenues ($ mn), Forecast, 2007-2012 39
Table 19: Blood Glucose
Meters, France, Overall Revenues ($ mn), Historic, 2000-2007 40
Table 20:
Blood Glucose Meters, France, Overall Revenues ($ mn), Forecast, 2007-2012
41
Table 21: Glucose Monitoring, France, Overall Volume (Units), Historic,
2000-2007 42
Table 22: Glucose Monitoring, France, Overall Volume (Units),
Forecast, 2007-2012 43
Table 23: Blood Glucose Test Strips, France,
Overall Volume (Units), Historic, 2000-2007 44
Table 24: Blood Glucose
Test Strips, France, Overall Volume (Units), Forecast, 2007-2012 45
Table
25: Blood Glucose Meters, France, Overall Volume (Units), Historic, 2000-2007
46
Table 26: Blood Glucose Meters, France, Overall Volume (Units),
Forecast, 2007-2012 47
Table 27: Blood Glucose Meters, France, Average
Price ($), Historic, 2000-2007 48
Table 28: Blood Glucose Meters, France,
Average Price ($), Forecast, 2007-2012 49
Table 29: Blood Glucose Test
Strips, France, Average Price ($), Historic, 2000-2007 50
Table 30: Blood
Glucose Test Strips, France, Average Price ($), Forecast, 2007-2012 51
Table 31: Glucose Monitoring, France, Distribution Share by Revenue ($ mn),
2006-2007 52
Table 32: Glucose Monitoring, France, Company Share by
Revenue ($ mn), 2006-2007 53
Table 33: Insulin Delivery, France, Overall
Revenues ($ mn), Historic, 2000-2007 54
Table 34: Insulin Delivery,
France, Overall Revenues ($ mn), Forecast, 2007-2012 55
Table 35: Insulin
Delivery, France, Revenue by Segment ($ mn), Historic, 2000-2007 56
Table
36: Insulin Delivery, France, Revenue by Segment ($ mn), Forecast, 2007-2012
57
Table 37: Insulin Pens, France, Overall Revenues ($ mn), Historic,
2000-2007 58
Table 38: Insulin Pens, France, Overall Revenues ($ mn),
Forecast, 2007-2012 59
Table 39: Insulin Pumps, France, Overall Revenues
($ mn), Historic, 2000-2007 60
Table 40: Insulin Pumps, France, Overall
Revenues ($ mn), Forecast, 2007-2012 61
Table 41: Insulin Syringes,
France, Overall Revenues ($ mn), Historic, 2000-2007 62
Table 42: Insulin
Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012 63
Table
43: Insulin Jet Injectors, France, Overall Revenues ($ mn), Historic,
2000-2007 64
Table 44: Insulin Jet Injectors, France, Overall Revenues ($
mn), Forecast, 2007-2012 65
Table 45: Insulin Delivery, France, Overall
Volume (Units), Historic, 2000-2007 66
Table 46: Insulin Delivery, France,
Overall Volume (Units), Forecast, 2007-2012 66
Table 47: Insulin Syringes,
France, Overall Volume (Units), Historic, 2000-2007 67
Table 48: Insulin
Syringes, France, Overall Volume (Units), Forecast, 2007-2012 68
Table 49:
Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007 69
Table
50: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012 70
Table 51: Insulin Pumps, France, Overall Volume (Units), Historic, 2000-2007
71
Table 52: Insulin Pumps, France, Overall Volume (Units), Forecast,
2007-2012 72
Table 53: Insulin Jet Injectors, France, Overall Volume
(Units), Historic, 2000-2007 73
Table 54: Insulin Jet Injectors, France,
Overall Volume (Units), Forecast, 2007-2012 74
Table 55: Insulin Jet
Injectors, France, Average Price ($), Historic, 2000-2007 75
Table 56:
Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012 76
Table 57: Insulin Pens, France, Average Price ($), Historic, 2000-2007 77
Table 58: Insulin Pens, France, Average Price ($), Forecast, 2007-2012 78
Table 59: Insulin Pumps, France, Average Price ($), Historic, 2000-2007 79
Table 60: Insulin Pumps, France, Average Price ($), Forecast, 2007-2012 80
Table 61: Insulin Syringes, France, Average Price ($), Historic, 2000-2007
81
Table 62: Insulin Syringes, France, Average Price ($), Forecast,
2007-2012 82
Table 63: Insulin Delivery, France, Distribution Share by
Revenue ($ mn), 2006-2007 83
Table 64: Insulin Delivery, France, Company
Share by Revenue ($ mn), 2006-2007 84
Table 65: F. Hoffmann-La Roche
Ltd., SWOT Analysis, 2006 92
Table 66: F. Hoffmann-La Roche Ltd.,
Financial Statements, CHF Million, 2002-2006 96
Table 67: F.
Hoffmann-La Roche Ltd., Financial Ratios, CHF Million, 2002-2006 97
Table
68: F. Hoffmann-La Roche Ltd., Other Locations 98
Table 69: F.
Hoffmann-La Roche Ltd., Other Locations(Contd..) 99
Table 70: F.
Hoffmann-La Roche Ltd., Subsidiaries 99
Table 71: LifeScan, Inc.,
Other Locations 102
Table 72: Abbott Laboratories, SWOT Analysis,
2006 113
Table 73: Abbott Laboratories, Financial Statements, USD
Thousand, 2002-2006 116
Table 74: Abbott Laboratories, Financial
Ratios, USD Thousand, 2002-2006 117
Table 75: Abbott Laboratories,
Other Locations 118
Table 76: Abbott Laboratories, Subsidiaries
119
Table 77: Novo Nordisk A/S, Other Locations 129
Table 78:
Novo Nordisk A/S, Subsidiaries 130
Table 79: Bayer HealthCare AG,
SWOT Analysis 141
Table 80: Bayer HealthCare AG, Other Locations
145
Table 81: Currency Conversion from USD to Local Currency at 2007
Constant Rate 171
1.2 List of Figures
Figure 1: Total Healthcare
Expenditure in France, 2000 -- 2006 20
Figure 2: Diabetes Care Devices,
France, Overall Revenues ($ mn), 2000-2012 24
Figure 3: Diabetes Care
Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 25
Figure 4:
Diabetes Care Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012
26
Figure 5: Diabetes Care Devices, France, Overall Revenues ($ mn),
2000-2012 27
Figure 6: Diabetes Care Devices, France, Overall Revenues ($
mn), Historic, 2000-2007 28
Figure 7: Diabetes Care Devices, France,
Overall Revenues ($ mn), Forecast, 2007-2012 29
Figure 8: Diabetes Care
Devices, France, Overall Volume (Units), 2000-2012 30
Figure 9: Diabetes
Care Devices, France, Overall Volume (Units), Historic, 2000-2007 31
Figure 10: Diabetes Care Devices, France, Overall Volume (Units), Forecast,
2007-2012 32
Figure 11: Diabetes Care Devices, France, Overall Company
Share (%), 2007 33
Figure 12: Glucose Monitoring, France, Overall Revenues
($ mn), Historic, 2000-2007 34
Figure 13: Glucose Monitoring, France,
Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure 14: Glucose
Monitoring, France, Revenue by Segment ($ mn), Historic, 2000-2007 36
Figure 15: Glucose Monitoring, France, Revenue by Segment ($ mn), Forecast,
2007-2012 37
Figure 16: Blood Glucose Test Strips, France, Overall
Revenues ($ mn), Historic, 2000-2007 38
Figure 17: Blood Glucose Test
Strips, France, Overall Revenues ($ mn), Forecast, 2007-2012 39
Figure 18:
Blood Glucose Meters, France, Overall Revenues ($ mn), Historic, 2000-2007
40
Figure 19: Blood Glucose Meters, France, Overall Revenues ($ mn),
Forecast, 2007-2012 41
Figure 20: Glucose Monitoring, France, Overall
Volume (Units), Historic, 2000-2007 42
Figure 21: Glucose Monitoring,
France, Overall Volume (Units), Forecast, 2007-2012 43
Figure 22: Blood
Glucose Test Strips, France, Overall Volume (Units), Historic, 2000-2007
44
Figure 23: Blood Glucose Test Strips, France, Overall Volume (Units),
Forecast, 2007-2012 45
Figure 24: Blood Glucose Meters, France, Overall
Volume (Units), Historic, 2000-2007 46
Figure 25: Blood Glucose Meters,
France, Overall Volume (Units), Forecast, 2007-2012 47
Figure 26: Blood
Glucose Meters, France, Average Price ($), Historic, 2000-2007 48
Figure
27: Blood Glucose Meters, France, Average Price ($), Forecast, 2007-2012
49
Figure 28: Blood Glucose Test Strips, France, Average Price ($),
Historic, 2000-2007 50
Figure 29: Blood Glucose Test Strips, France,
Average Price ($), Forecast, 2007-2012 51
Figure 30: Glucose Monitoring,
France, Distribution Share (%), 2007 52
Figure 31: Glucose Monitoring,
France, Company Share (%), 2007 53
Figure 32: Insulin Delivery, France,
Overall Revenues ($ mn), Historic, 2000-2007 54
Figure 33: Insulin
Delivery, France, Overall Revenues ($ mn), Forecast, 2007-2012 55
Figure
34: Insulin Delivery, France, Revenue by Segment ($ mn), Historic, 2000-2007
56
Figure 35: Insulin Delivery, France, Revenue by Segment ($ mn),
Forecast, 2007-2012 57
Figure 36: Insulin Pens, France, Overall Revenues
($ mn), Historic, 2000-2007 58
Figure 37: Insulin Pens, France, Overall
Revenues ($ mn), Forecast, 2007-2012 59
Figure 38: Insulin Pumps, France,
Overall Revenues ($ mn), Historic, 2000-2007 60
Figure 39: Insulin Pumps,
France, Overall Revenues ($ mn), Forecast, 2007-2012 61
Figure 40: Insulin
Syringes, France, Overall Revenues ($ mn), Historic, 2000-2007 62
Figure
41: Insulin Syringes, France, Overall Revenues ($ mn), Forecast, 2007-2012
63
Figure 42: Insulin Jet Injectors, France, Overall Revenues ($ mn),
Historic, 2000-2007 64
Figure 43: Insulin Jet Injectors, France, Overall
Revenues ($ mn), Forecast, 2007-2012 65
Figure 44: Insulin Syringes,
France, Overall Volume (Units), Historic, 2000-2007 67
Figure 45: Insulin
Syringes, France, Overall Volume (Units), Forecast, 2007-2012 68
Figure
46: Insulin Pens, France, Overall Volume (Units), Historic, 2000-2007 69
Figure 47: Insulin Pens, France, Overall Volume (Units), Forecast, 2007-2012
70
Figure 48: Insulin Pumps, France, Overall Volume (Units), Historic,
2000-2007 71
Figure 49: Insulin Pumps, France, Overall Volume (Units),
Forecast, 2007-2012 72
Figure 50: Insulin Jet Injectors, France, Overall
Volume (Units), Historic, 2000-2007 73
Figure 51: Insulin Jet Injectors,
France, Overall Volume (Units), Forecast, 2007-2012 74
Figure 52: Insulin
Jet Injectors, France, Average Price ($), Historic, 2000-2007 75
Figure
53: Insulin Jet Injectors, France, Average Price ($), Forecast, 2007-2012
76
Figure 54: Insulin Pens, France, Average Price ($), Historic, 2000-2007
77
Figure 55: Insulin Pens, France, Average Price ($), Forecast, 2007-2012
78
Figure 56: Insulin Pumps, France, Average Price ($), Historic,
2000-2007 79
Figure 57: Insulin Pumps, France, Average Price ($),
Forecast, 2007-2012 80
Figure 58: Insulin Syringes, France, Average Price
($), Historic, 2000-2007 81
Figure 59: Insulin Syringes, France, Average
Price ($), Forecast, 2007-2012 82
Figure 60: Insulin Delivery, France,
Distribution Share (%), 2007 83
Figure 61: Insulin Delivery, France,
Company Share (%), 2007 84
Figure 62: F. Hoffmann-La Roche Ltd.,
Value Chain Analysis 89
Figure 63: Abbott Laboratories, Value Chain
Analysis 110
Figure 64: Bayer HealthCare AG, Value Chain Analysis
139
Figure 65: Flowchart for Classification of Non-invasive Devices in
France, 2007 153
Figure 66: Flowchart for Classification of Invasive
Devices in France, 2007 154
Figure 67: Flowchart for Classification of
Invasive Devices in France, 2007 155
Figure 68: Flowchart for
Classification of Invasive Devices in France, 2007 156
Figure 69:
Flowchart for Classification of Invasive Devices in France, 2007 157
Figure 70: Flowchart for Classification of Active Devices in France, 2007
158
Figure 71: Flowchart for Classification of Active Devices in France,
2007 159
Figure 72: Flowchart for Classification of Devices except
Non-invasive, Invasive and Active Devices in France, 2007 160
Figure 73:
Conformity Assessment of Class-I Medical Devices in France, 2007 161
Figure 74: Conformity Assessment of Class-IIa Medical Devices in France, 2007
162
Figure 75: Conformity Assessment of Class-IIb Medical Devices in
France, 2007 163
Figure 76: Conformity Assessment of Class-III Medical
Devices in France, 2007 164
Figure 77: Medical Equipment Distribution
Structure in France, 2007 166
Figure 78: Global Markets Direct Methodology
167